Navigation Links
PharmAthene Reports First Quarter 2008 Financial Results
Date:5/13/2008

87,121 shares issued and

outstanding; respectively, at

March 31, 2008 and December 31, 2007 2,209 2,209

Additional paid-in capital 127,278,108 126,490,647

Accumulated other comprehensive income 1,260,704 1,481,779

Accumulated deficit (92,420,179) (87,402,551)

Total stockholders' equity 36,120,842 40,572,084

Total liabilities and stockholders'

equity $62,223,155 $66,611,132

PharmAthene, Inc.

Consolidated Statements of Operations

(Unaudited)

Three months ended March 31,

2008 2007

(unaudited)

Contract and grant revenue $5,819,054 $2,961,759

Other revenue 21,151 7,000

5,840,205 2,968,759

Operating expenses:

Research and development 5,877,055 3,091,604

General and administrative 4,678,723 2,479,825

Depreciation and amortization 196,103 147,133

Total operating expenses 10,751,881 5,718,562

Loss from operations (4,911,676) (2,749,803)

Other income (expense):

Interest income 471,765 55,616

Interest expense (666,997) (241,781)

Change in market value of derivative

instruments 89,280 7,626

Total other expense (105,952)
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008
2. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
3. PharmAthene Reports Year-End 2007 Financial Results
4. Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthenes Protexia(R) Program
5. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
6. PharmAthene to Delay Release of Full Year 2007 Financial Results
7. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
11. PharmAthene to Present at the BIO CEO & Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo announced ... from the National Institutes of Health (NIH) to help ... effective treatments to patients on a faster timeline. Organovo ... Sciences (NCATS) and the National Eye Institute (NEI) to ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Europe, NEWPORT NEWS, Va., May 6 Dilon ... Europeenne) approval for the,commercial sale of the Dilon 6800 ... is a high-resolution gamma camera that enables,molecular imaging of ... "I am delighted that our high technology camera ...
... today announced that,it has enhanced its leadership ... in the United States and abroad as ... this development. Jacqueline Hall has been,appointed global ... Ph.D. has been appointed vice president and ...
... to Commercialize Leading OAB Drug in China, ... Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or ... ("CTA") for Enablex(R),(Darifenacin) was officially accepted by China,s ... a key SFDA requirement prior to,pursuing a clinical ...
Cached Biology Technology:MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments 2MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments 3BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial 2BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial 3
(Date:4/24/2014)... is a commercially important sugar used as a ... compound for synthesizing riboflavin and several antiviral drugs. ... increase the bacteria,s ability to produce D-ribose is ... production of this valuable chemical, as described in ... peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
(Date:4/24/2014)... identified the structural features that enable the innate ... RNAs in living cells. , When viruses infect ... hijack cellular resources for the production of viral ... molecules that are delivered directly to (in the ... the host cell, and provide the blueprints for ...
(Date:4/24/2014)... With a new generation of military veterans returning home ... become a prominent concern in American medical institutions and ... 35 percent of personnel deployed to Iraq and Afghanistan ... South Carolina School of Medicine is shedding light on ... and surprising ways. , The rise in PTSD has ...
Breaking Biology News(10 mins):Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3
... the breakdown of cognition processes and typical emotional and ... believe that several genes are associated with an increased ... the disease by itself. It is likely that interactions ... to develop and that epigenetic change also plays a ...
... Studies and the Woodrow Wilson International Center for Scholars ... Science Foundation (NSF) to help realize potential benefits and ... The grant is supported jointly by three ... Biology, the Division of Environmental Biology, and the Engineering ...
... generally deleterious, even in flowering plants. Since inbreeding raises ... be expressed, inbred progeny suffer from reduced viability. ... reject their own pollen, thereby preventing inbreeding despite the ... that involves the interaction of a gene that tags ...
Cached Biology News:How does inbreeding avoidance evolve in plants? 2
... Start up kit. Includes configured Laptop PC ... 2 MultiBlock satellite thermal cyclers (non-robotic). ... User friendly software. Store/track run data. ... lid. Outstanding uniformity. Advanced control ...
Glycerokinase; from Bacillus stearothermophilus...
A compact, high-speed single tube reader unit designed for benchtop 2D barcode reading. The unit can be used with all of ABgene's 2D barcoded tubes, including the 2ml CryoCode tube....
... Ascent FL is equipped ... luminometric measurement technologies that ... of advanced features of ... Ascent. Fluoroskan Ascent FL ...
Biology Products: